Specifically, the main purpose of our research was to demonstrate the potential role of RANK expression in primary tumors as a predictive marker of bone metastasis occurrence and skeletal disease-free survival (SDFS) in a population of breast cancer patients. This evidence concerns the gene TNFRSF11A and breast cancer.